Notably, SSTR2-SST has been significantly associated to higher survival rates in Epstein-Barr virus (EBV)-nasopharyngeal cancer, a class of head and neck cancer, and its targeting with a peptide-drug conjugate (i.e., PEN-221) has been proposed to treat this type of tumor.39 The gene discussed is SST; the disease is head and neck cancer.